亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Readmission Within 90 Days After Primary THA Is Associated With Decreased Improvement in 1-Year Patient-reported Outcome Measures and Increased Reoperation Rates

医学 最小临床重要差异 骨科手术 患者报告的结果 外科 患者满意度 物理疗法 生活质量(医疗保健) 急诊医学 随机对照试验 护理部
作者
Shujaa T Khan,Ignacio Pasqualini,Yuxuan Jin,Alison K. Klika,Nicolás S. Piuzzi
出处
期刊:Clinical Orthopaedics and Related Research [Ovid Technologies (Wolters Kluwer)]
标识
DOI:10.1097/corr.0000000000003429
摘要

Background Readmissions after THA can negatively impact patients, increase healthcare utilization, and subsequently increase costs. However, there is little to demonstrate whether readmission after THA is associated with poorer results in outcomes that matter to patients, such as pain relief, restoration of function, or activities of daily living. Moreover, the impact of medical-related readmissions compared with orthopaedic-related readmissions on postoperative outcomes is currently unknown. Questions/purpose Are patients readmitted within 90 days of an index THA less likely to achieve a minimum clinically important difference (MCID) or patient acceptable symptom state (PASS) threshold in postoperative patient-reported outcome measures (PROMs) compared with those who are not readmitted? (2) Is the cause of readmission within 90 days (medical or orthopaedic) associated with a lower likelihood of achieving either MCID or PASS thresholds 1 year after THA? (3) How does 90-day readmission compare with other patient-specific factors associated with a lower likelihood of attaining either MCID or PASS? (4) Are patients readmitted within 90 days more likely to undergo further surgery? Methods Between January 2016 and December 2020, we treated 11,026 patients with primary THA at a large tertiary academic center. Patients undergoing nonelective (n = 551) and bilateral THAs (n = 1582) were excluded, leaving 8893 for final analysis here. Of these, 2476 patients were lost to follow-up and thus not included in the 1-year PROMs analysis, but they remained included in the study overall. Data for each patient were extracted from a validated longitudinally maintained institutional database. The mean ± SD age of patients was 65 ± 11.5 years, 57% were women, and 86% self-reported as White. Readmissions were individually reviewed and grouped into medical-related or orthopaedic-related causes based on the primary cause. Multivariable logistic regression models were used to investigate the association of 90-day readmission with 1-year PROMs. Overall, 6% (502 of 8893) were readmitted within 90 days, with 75% (377 of 502) being medically related and 25% (125 of 502) being orthopaedically related readmissions. PROM scores were obtained preoperatively and at 1 year after each of the THAs and included Hip Disability and Osteoarthritis Outcome Score (HOOS) pain, physical function, and joint replacement scores, as well as the Veterans Rand 12-Item Health Survey mental component summary score. Each was scored from 0 to 100, with higher scores representing better patient-perceived outcomes. Anchor-based MCID (HOOS pain 33, HOOS physical function 34, and HOOS joint replacement 18) and PASS thresholds (HOOS pain 80.6, HOOS physical function 83.6, and HOOS joint replacement 76.8) were utilized. Results Patients readmitted within 90 days of an index THA were less likely to achieve the MCID in HOOS joint replacement (OR 1.5 [95% confidence interval (CI) 1.1 to 2.06]; p = 0.01). Similarly, compared with patients who were not readmitted, readmitted patients were less likely to achieve PASS thresholds in HOOS pain (OR 1.37 [95% CI 1.07 to 1.77]; p = 0.01) and HOOS joint replacement (OR 1.4 [95% CI 1.05 to 1.92]; p = 0.02). Patients readmitted for orthopaedic causes compared with those not readmitted were less likely to achieve the MCID in HOOS joint replacement (OR 2.59 [95% CI 1.56 to 4.31]; p < 0.001) and the PASS threshold in HOOS pain (OR 1.79 [95% 1.12 to 2.86]; p = 0.02) and HOOS joint replacement (1.76 [95% CI 1.06 to 2.93]; p = 0.03) at 1 year. However, patients readmitted for medical causes, compared with patients who were not readmitted, were not less likely to achieve MCID or PASS thresholds in any of the HOOS subscales. The 90-day readmission (Akaike information criterion [AIC] increase 14.1) was the sixth most important variable influencing the likelihood of not achieving the MCID in HOOS joint replacement, following PROM phenotype (AIC 265), opioid use (Narx score), smoking, insurance, and race. Similarly, 90-day readmission ranked as the seventh and sixth most important variable for not achieving PASS thresholds in HOOS pain (AIC increase 7.5) and HOOS joint replacement (AIC increase 8.3), respectively. Patients readmitted within 90 days were more likely to undergo further surgery compared with those who were not readmitted (20.3% versus 0.04%; p < 0.001). Conclusion Although medical-related readmissions are more frequent after THA, patients readmitted for orthopaedic causes are less likely to perceive meaningful improvements in pain relief and hip function at 1 year. Surgeons can reassure patients readmitted for medical reasons that their long-term symptom relief and functional recovery remain achievable. These findings highlight the importance of specifically identifying patients at higher risk of orthopaedic-related readmissions and implementing personalized preoperative optimization strategies tailored to their specific risk factors to reduce the chance of complications that may lead to readmission. Future studies should focus on identifying optimal management strategies for readmitted patients to ensure that they continue to perceive substantial benefits in their hip symptoms and function after surgery. Level of Evidence Level III, therapeutic study.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
16秒前
23秒前
Chen发布了新的文献求助10
28秒前
MchemG应助科研通管家采纳,获得10
32秒前
科研通AI6应助科研通管家采纳,获得10
32秒前
科研通AI6应助科研通管家采纳,获得10
32秒前
MchemG应助科研通管家采纳,获得10
32秒前
科研通AI2S应助科研通管家采纳,获得10
32秒前
科研通AI6应助科研通管家采纳,获得10
32秒前
32秒前
科研通AI2S应助科研通管家采纳,获得10
32秒前
MchemG应助科研通管家采纳,获得10
32秒前
32秒前
32秒前
MchemG应助科研通管家采纳,获得10
32秒前
33秒前
40秒前
慕青应助smm采纳,获得10
48秒前
三年三班三井寿完成签到,获得积分10
53秒前
54秒前
taster发布了新的文献求助10
58秒前
传奇3应助taster采纳,获得10
1分钟前
1分钟前
1分钟前
土豆你个西红柿完成签到 ,获得积分10
1分钟前
共享精神应助Sunny采纳,获得10
1分钟前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
阿翼完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
smm发布了新的文献求助10
2分钟前
朴素的啤酒完成签到,获得积分10
2分钟前
2分钟前
2分钟前
明亮豆芽完成签到 ,获得积分10
2分钟前
Chen完成签到,获得积分10
2分钟前
陈sir完成签到 ,获得积分10
2分钟前
高分求助中
2025-2031全球及中国金刚石触媒粉行业研究及十五五规划分析报告 25000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Russian Foreign Policy: Change and Continuity 800
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5706099
求助须知:如何正确求助?哪些是违规求助? 5169547
关于积分的说明 15246547
捐赠科研通 4859746
什么是DOI,文献DOI怎么找? 2608048
邀请新用户注册赠送积分活动 1559009
关于科研通互助平台的介绍 1516762